A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability
Resveratrol (RES) has a low bioavailability. This limitation was addressed in an earlier review and several recommendations were offered. A literature search was conducted in order to determine the extent of the research that was conducted in line with these recommendations, along with new developme...
Main Authors: | Konrad de Vries, Morné Strydom, Vanessa Steenkamp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/14/4367 |
Similar Items
-
Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies
by: Niege A. J. C. Furtado, et al.
Published: (2017-03-01) -
Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids
by: Ondrej Vesely, et al.
Published: (2021-09-01) -
Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes
by: Mubashir Ahmad, et al.
Published: (2023-04-01) -
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM)
by: Christopher Kemper, et al.
Published: (2022-06-01) -
Improvement of bioavailability for resveratrol through encapsulation in zein using electrospraying technique
by: Heera Jayan, et al.
Published: (2019-06-01)